Anti-Venom Market accounted for US$ 2.60 billion in 2020 and is estimated to be US$ 4.70 billion by 2030 and is anticipated to register a CAGR of 6.1%.anti-venom market is driven owing to it is unique treatment option available for insect bites specifically for snake. Further, growing incidences of scorpion bites, snake bites, and other animal or insect bites such as fish stings also drives growth of the anti-venom market.

The report “Anti-Venom Market, By Type (Monovalent and Polyvalent), By Animal Type (Snake, Scorpion, Spider and Others), By Distribution Channel (Hospital, Retail Pharmacies and Others), and Region - Global Forecast to 2030"

Key Highlights:

• In 2018, Pfizer, Inc. worked with the U.S. Food and Drug Administration (FDA), to extend the expiration date of Antivenin’s Lot No. L67530 for an additional 12 months.

Key Market Insights from the report:          

Anti-Venom Market accounted for US$ 2.60 billion in 2020 and is estimated to be US$ 4.70 billion by 2030 and is anticipated to register a CAGR of 6.1%.The market report has been segmented on the basis of type, animal type, distribution channel, and region.

• By type, the anti-venom market is segmented into monovalent and polyvalent.
• By animal type, the anti-venom market is segmented into snake, scorpion, spider and others.
• By distribution channel, the anti-venom market is segmented into hospital, retail pharmacies and others.
• By region, the North America region accounted major share in the anti-venom market and is expected to retain its dominance over forecast period. This is attributed to the increasing incidences of scorpion bites and snake bites and rising expenditure on healthcare in North America region.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Anti-Venom Market”, By Type (Monovalent and Polyvalent), By Animal Type (Snake, Scorpion, Spider and Others), By Distribution Channel (Hospital, Retail Pharmacies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - forecast till 2029

The prominent player operating in the anti-venom market include Boston Scientific Corporation, CSL Limited, Pfizer, Inc., Merck & Co., Inc., Bharat Serums and Vaccines Limited, Haffkine Bio-Pharmaceutical Corporation Ltd., Vins Bioproducts Limited, Incepta Pharmaceuticals Ltd., Medline Industries Inc. and Rare Disease Therapeutics Inc.

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2574

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com